News
Stand Up To Cancer Supports Innovative Research Grants for 10 Early-Career Scientists
NEW ORLEANS — Stand Up To Cancer (SU2C) announced Monday that it is awarding 10 grants of $750,000 each to early-career scientists to support innovative, high-risk, high-reward projects in cancer research. The announcement was made at the 2016 Annual Meeting of the American Association for Cancer
Gene Mutation Makes Tumors Tense, Worsens Patient Prognosis
UC San Francisco researchers have discovered that the chances of survival for patients with pancreatic adenocarcinoma (PDAC) — the most common type of pancreatic cancer — may depend in part on how tense their tumors are. The researchers provide the first evidence linking tumor aggressiveness and
New Cancer Immunotherapy Clinic Offers Unique Studies of Promising Treatments
UC San Francisco oncologist Lawrence Fong, MD, personifies the tremendous excitement among cancer physicians over the growing potential of new immunotherapies. He smiles often as he explains how the body’s own immune system – long thought to be an ineffective slacker when it comes to combatting
UCSF Immunologist to Head New Parker Institute for Cancer Immunotherapy
Renowned UC San Francisco immunologist Jeffrey Bluestone, PhD, has been named president and CEO of the Parker Institute for Cancer Immunotherapy, a national initiative launched with a $250 million grant from The Parker Foundation, a private philanthropic organization established by Silicon Valley
American Association for Cancer Research Elects UCSF Faculty to Board of Directors, Nominating Committee
PHILADELPHIA — The members of the American Association for Cancer Research (AACR) have elected five members to serve on the AACR Board of Directors for the 2016-2019 term and four members to serve on the nominating committee for the 2016-2018 term. They will begin their terms at the AACR Annual
Berger, Bluestone Named to White House Cancer Moonshot Expert Panel
Mitchel Berger, MD, and Jeff Bluestone, PhD, have been named to a Blue Ribbon Panel of scientific experts, cancer leaders and patient advocates that will help to guide the National Cancer Moonshot Initiative. The UC San Francisco faculty members will help to inform the scientific direction and goals
UCSF Researchers Receive Prestigious NCI Outstanding Investigator Awards
Three researchers from the UCSF Helen Diller Family Comprehensive Cancer Center have received the NCI Outstanding Investigator Award in 2015: Thea D. Tlsty, PhD, Frank McCormick, PhD, FRS, DSc (Hon), and Markus Müschen, MD, PhD. NCI’s Outstanding Investigator Award supports accomplished leaders in